ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541)
HK$ 14.6 0.4 (2.82%) Market Cap: 5.46 Bil Enterprise Value: 4.88 Bil PE Ratio: 0 PB Ratio: 6.67 GF Score: 18/100

ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) Transcripts

    • 1